---
schema_version: "secwatch.filing_event.v1"
accession: "0000070318-24-000011"
form_type: "8-K"
ticker: "THC"
cik: "0000070318"
company_name: "TENET HEALTHCARE CORP"
filed_at: "2024-02-08T23:59:59+00:00"
generated_at: "2026-06-06T06:03:52.876043+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Tenet Q4 net income $244M, adj EBITDA $1.012B (+12.8% YoY); 2024 outlook $3.285-3.485B adj EBITDA

## Summary
- Q4 GAAP diluted EPS $2.30 vs $0.92 YoY; adjusted diluted EPS $2.68 vs $1.96.
- Ambulatory Care adj EBITDA $464M (+14.0% YoY) on 3.9% same-facility surgical case growth.
- Completed sale of three SC hospitals to Novant Health for ~$2.4B on Feb 1; signed deal to sell four CA hospitals to UCI Health for ~$975M.
- FY 2024 outlook: adj EBITDA $3.285B-$3.485B; net rev $19.9B-$20.3B; adj EPS $5.76-$6.90.
- Q4 hospital segment adj EBITDA excl. grant income $546M vs $450M YoY; same-hospital non-COVID admissions +2.6%.

## SEC filing metadata
- accession: 0000070318-24-000011
- form_type: 8-K
- ticker: THC
- cik: 0000070318
- company_name: TENET HEALTHCARE CORP
- filed_at: 2024-02-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/70318/000007031824000011/0000070318-24-000011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/70318/000007031824000011/thc-20240208.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000070318-24-000011
- JSON: https://secwatch.observer/filing/0000070318-24-000011.json
- Plain text: https://secwatch.observer/filing/0000070318-24-000011.txt

## Key facts
- Earnings Releases
  TENET HEALTHCARE CORP reported the quarter ended December 31, 2023 results: revenue $5,379, net income $244 million, EPS $2.30 per diluted share. Guidance raised.
  - Period: the quarter ended December 31, 2023
  - Revenue: $5,379
  - Net income: $244 million
  - EPS: $2.30 per diluted share
  - Guidance: raised
  - Result: reported results
  source text: 2022 are as follows: Three Months Ended December 31, Twelve Months Ended December 31, ($ in millions, except per share results) 2023 2022 2023 2022 Net operating revenues $5,379 $4,990 $20,548 $19,174 Net income available to Tenet common shareholders from continuing operations $244 $102 $611 $410 Net income available to Tenet common shareholders from
  evidence_url: https://www.sec.gov/Archives/edgar/data/70318/000007031824000011/0000070318-24-000011-index.htm
- Earnings Releases
  TENET HEALTHCARE CORP reported the year ended December 31, 2023 results: revenue $20,548, net income $611 million, EPS $5.71 per diluted share. Guidance raised.
  - Period: the year ended December 31, 2023
  - Revenue: $20,548
  - Net income: $611 million
  - EPS: $5.71 per diluted share
  - Guidance: raised
  - Result: reported results
  source text: as follows: Three Months Ended December 31, Twelve Months Ended December 31, ($ in millions, except per share results) 2023 2022 2023 2022 Net operating revenues $5,379 $4,990 $20,548 $19,174 Net income available to Tenet common shareholders from continuing operations $244 $102 $611 $410 Net income available to Tenet common shareholders from continuing
  evidence_url: https://www.sec.gov/Archives/edgar/data/70318/000007031824000011/0000070318-24-000011-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.